Skip to main content
I

Instatininc

The startup develops inhaled statin therapies for the treatment of chronic lung diseases, including COVID-19, asthma, and chronic obstructive pulmonary disease. By utilizing targeted inhalation delivery, the company aims to enhance drug efficacy and improve patient management in respiratory care.

Traction –/10
Sacramento, United States · HQ
  • Biotechnology
  • Healthcare Technology
Updated 5 months ago

Funding

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

  • The startup develops inhaled statin therapies for the treatment of chronic lung diseases, including COVID-19, asthma, and chronic obstructive pulmonary disease. By utilizing targeted inhalation delivery, the company aims to enhance drug efficacy and improve patient management in respiratory care.
This profile is AI-generated and may contain inaccuracies.